Company Overview of Caladrius Biosciences, Inc.
Hans S. Keirstead Ph.D.
Chief Science Officer, Senior Vice President of Research and President of NeoStem Oncology, Caladrius Biosciences, Inc.
|Age||Total Calculated Compensation||This person is connected to 5 Board Members in 5 different organizations across 7 different industries.|
See Board Relationships
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships
President, Chief Executive Officer, and Director
University of Cambridge
University Of British Columbia
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|Robin C. Stracey||Chief Executive Officer and Director|
Cesca Therapeutics Inc.
|Marc H. Hedrick M.D.||Chief Executive Officer, President, Director and Member of Executive Committee|
Cytori Therapeutics, Inc.
|Martin M. McGlynn||Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc|
|Dean Tozer||Chief Executive Officer, President and Director|
Nuo Therapeutics, Inc.
|Linda Marban Ph.D.||Co-Founder, Chief Executive Officer, President and Director|
Capricor Therapeutics, Inc.
|$232.9K||Compensation as of Fiscal Year 2015.|